March 19, 2018 / 9:02 PM / 8 months ago

BRIEF-Cellect Biotechnology Q4 Loss Per Share ‍$0.008​

March 19 (Reuters) - Cellect Biotechnology Ltd:

* CELLECT BIOTECHNOLOGY PROVIDES CORPORATE UPDATE AND REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

* CELLECT BIOTECHNOLOGY LTD - QTRLY LOSS PER SHARE ‍$0.008​

* CELLECT BIOTECHNOLOGY - ‍CASH AND CASH EQUIVALENTS TOTALED $8.0 MILLION AS OF DEC 31, 2017, COMPARED TO $9.4 MILLION ON SEPT 30, 2017​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below